AI scans CTs to match kidney cancer patients with best drug
NCT ID NCT07332923
Summary
This study is developing a computer model to help doctors make more personalized treatment decisions for kidney cancer. By analyzing past patient data and CT scans, the model aims to predict which patients are most likely to benefit from a specific targeted drug called Belzutifan. The goal is to better match patients with effective treatments while avoiding unnecessary side effects from drugs that may not work for them.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RADIOMICS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
first hospital affiliated of Fujian medical university
Fuzhou, Fujian, 350005, China
Conditions
Explore the condition pages connected to this study.